Abcellera Biologics Inc Revenue per Employee (ABCL), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Abcellera Biologics Inc   (NASDAQ: ABCL)
 

Abcellera Biologics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Abcellera Biologics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 117,747, below the company average number of $313,167.
Within the Healthcare sector Employees of 441 other companies have achieved higher revenue per employee. While Abcellera Biologics Inc 's total ranking has deteriorated compared to the previous quarter from 2456 to 3262. Abcellera Biologics Inc has 562 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABCL Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change -76.29 % 96.34 % 788.37 % 37.62 % 133.29 %
Sales per Employee (TTM) $ 117,747 140,940 133,680 62,852 58,496
ABCL's Total Ranking # 3262 # 2456 # 1471 # 2071 # 2286
Seq. Revenue Change -51.29 % -81.46 % 400.88 % -47.58 % 303.4 %

ABCL Company Profile >> Back to ABCL Efficiency Comparisons >> Compare ABCL Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 162
Healthcare Sector # 442
Overall Market # 3262

Revenue per Employee Statistics
High Average Low
$ 1,073,295 $ 313,167 $ 41,128
(Sep 30 2022)   (Mar 31 2025)



Financial Statements
Abcellera Biologics Inc 's Revenue MRQ $ 4 Millions Visit ABCL's Income Statement
Abcellera Biologics Inc 's Revenues TTM $ 66 Millions Visit ABCL's aggregate revenue growth
What are ABCL's Sales? Visit ABCL's Sales by Segment




Other Ratios
Abcellera Biologics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ABCL's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ABCL's Competitors
Revenue per Employee for ABCL's Suppliers
Revenue per Employee for ABCL's Customers

You may also want to know
ABCL's Sales Growth Rates ABCL's Pe Price to earnings ratio ABCL's Receivables Turnover Ratio ABCL's Stock Quote
ABCL's Net Income Growth Rates ABCL's Ps Price to Sales ratio ABCL's Sales per Employee ABCL's Asset Turnover Ratio
ABCL's Net Margin ABCL's Pb Price to Book ratio ABCL's Financial Strength Ratios ABCL's Dividend Payout Ratio
Date modified: 2026-09-09T01:58:04+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Labcorp Holdings Inc   204,971.43 $ 14,348.000  Million 70,000 
Tonix Pharmaceuticals Holding Corp   204,943.66 $ 29.102  Million 142 
Bolt Biotherapeutics Inc   204,347.83 $ 4.700  Million 23 
Tenon Medical Inc   204,307.69 $ 5.312  Million 26 
Align Technology inc   203,970.77 $ 4,138.567  Million 20,290 
Charles River Laboratories International inc   202,994.26 $ 3,998.987  Million 19,700 
Quest Diagnostics Inc  202,807.02 $ 11,560.000  Million 57,000 
Rapid Micro Biosystems Inc   202,017.54 $ 34.545  Million 171 
Sbc Medical Group Holdings Incorporated  201,289.79 $ 173.713  Million 863 
Hcw Biologics Inc   195,508.54 $ 6.843  Million 35 
Utah Medical Products Inc  194,967.21 $ 35.679  Million 183 
Arcus Biosciences Inc   194,675.54 $ 117.000  Million 601 
Gyre Therapeutics Inc   193,176.38 $ 119.383  Million 618 
Tao Synergies Inc   193,124.75 $ 0.772  Million 4 
Safe Pro Group Inc   192,088.60 $ 2.881  Million 15 
Monte Rosa Therapeutics Inc   191,513.33 $ 28.727  Million 150 
Fortrea Holdings Inc   187,167.83 $ 2,676.500  Million 14,300 
Agios Pharmaceuticals Inc   182,107.41 $ 98.338  Million 540 
Grail Inc   181,607.69 $ 165.263  Million 910 
Davita Inc   179,610.85 $ 14,009.646  Million 78,000 
Universal Health Services Inc   178,467.85 $ 18,114.487  Million 101,500 
Concentra Group Holdings Parent Inc   175,958.85 $ 2,287.465  Million 13,000 
Lineage Cell Therapeutics Inc   169,909.09 $ 13.083  Million 77 
Integer Holdings Corporation  167,511.00 $ 1,842.621  Million 11,000 
Bioage Labs Inc   167,016.13 $ 10.355  Million 62 
Retractable Technologies Inc  166,605.48 $ 33.488  Million 201 
Icu Medical Inc  166,153.69 $ 2,159.998  Million 13,000 
Prophase Labs Inc   165,789.47 $ 3.150  Million 19 
Bionexus Gene Lab Corp   164,556.89 $ 3.127  Million 19 
Chemed Corporation  164,126.30 $ 2,595.001  Million 15,811 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.